Aviva has reported its protection and health sales increased 5% in Q1 of 2024 to £106 million, compared to £102m in the same period last year.
The increase in sales was driven by growth in protection, with group protection sales up 15% to £38m from £33m in Q1 2023, which Aviva said reflects strong new scheme wins. Additionally, individual protection sales increased to £37m from £36m last year. Aviva said it also experienced continued momentum in health with double-digit growth of in-force premiums from the prior year. However, sales were down 6% from £33m last year to £31m, which Aviva noted was expected due to a strong prior year performance in corporate, following the exit of another provider from the market. In April ...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.